Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type (1 selected)

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 851 to 875 of 2047

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Brain tumours (primary) and brain metastases in over 16sNG99
Minimally invasive radical hysterectomy for early stage cervical cancerHTG565
The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to healHTG566
Self-expanding implant insertion into the intersphincteric space for faecal incontinenceHTG564
Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitorTA670
The PLASMA system for transurethral resection and haemostasis of the prostateHTG563
Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancerTA668
Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinomaTA666
Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpuraTA667
PancreatitisNG104
Eating disorders: recognition and treatmentNG69
Diabetes in pregnancy: management from preconception to the postnatal periodNG3
Peripheral arterial disease: diagnosis and managementCG147
Low back pain and sciatica in over 16s: assessment and managementNG59
Liraglutide for managing overweight and obesityTA664
Upadacitinib for treating severe rheumatoid arthritisTA665
Zio XT for detecting cardiac arrhythmiasHTG562
Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancerTA660
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinomaTA661
Durvalumab in combination for untreated extensive-stage small-cell lung cancer (terminated appraisal)TA662
Swallowable gastric balloon capsule for weight lossHTG561
Drug-eluting stents for the treatment of coronary artery diseaseTA152
Guidance on the use of coronary artery stentsTA71
Siponimod for treating secondary progressive multiple sclerosisTA656
Carfilzomib for previously treated multiple myelomaTA657

Results per page

  1. 10
  2. 25
  3. 50
  4. All